Low risk pragmatic trials do not always require participants’ informed consent

Rafael Dal‐Ré, C. Avendaño, Brigitte Bloechl‐Daum, Anthonius de Boer, Stefan Eriksson, Uwe Fuhr, Søren Holm, Stefan James, Robert J. Mentz, Emilio Perucca,

BMJ · 2019 · 38 citations · 24 references

DOIFull text

Open access

Concepts

Abstract

Clinical trial regulations should remove unnecessary obstacles for the conduct of pragmatic trials assessing the comparative effectiveness of medicines posing no or minimal risk to participants, say <b>Rafael Dal-Ré and colleagues</b>

References

24